steamloss in the Genmab stock will likely fuel a new rush.
1) the 2 previous times times RSI has been below 30, it has resulted in strong returns. Will it happen a 3rd time?
2) The current strongly rising RSI will like make sure that the price will move and stay above the short term downward trend.
3) Opportunity for the price to move towards 2557 DKK. Yet be...
Syndax Pharmaceuticals recently had POSITIVE interim data on their phase 2 study in SNDX-5613 for Leukemia. This data was positive as they saw a 48% overall response rate in patients with MLLr or NPM1c; 67% of responders achieved minimal residual disease-negative status. Out of 43 of patients evaluated, 31 were able to be used as for significant data. These two...
After some conversation with a young single mom and what she goes through to get her and her 2 yr old diabetes meds @ $13hr...f to the big pharma and f to the health care that does not cover such a life saving drug. It's not a conspiracy...it's a cultural failure to recognize how far we have come in such a short time. Some will call it profiteering...sure but it's...
There is good indication of reversal and trend change from 30th March onwards. Two dates are mentioned in the chart.
Target 215 ++ (20% ++ profit from here)
Follow me for more ideas like this.
With a multi-year breakout and current pharma sector conditions, I believe it's going to outperform the sector.
Disclaimer: for education purposes only not recommended for trade.
can use both weekly and daily timeframe for getting the big picture.
Check the notes points for further clarity
#sunpharma
Levels -
Buy - Any dip the CMP or it breaks above 628
T1 - 645
T2 - 700
SL - 610
The undertone of the Pharma sector is bullish amid the second wave of COVID-19 hitting India. Sun Pharmaceuticals has the largest market capitalization and is currently trading at half the price of its all-time high which was close to 1200. The stock has seen a major correction from...
Possibility to gain again?
It looks like it want to crawl up on a support line (green).
I've packed bags here a little.
Indicators are almost reversed to bullish.
But it still can go lower if it breaks the support line.
Remember to have a stop loss below the support line.
There is a big gap below 5.60.
There also could happen a bear trap, quick fall and then...
Set up looks great. Triple bottom, break out and retest of a diagonal resistance. I absolutely dislike stocks like this but I like the chart. Will there be a catalyst to move this? The only catalyst for this one is the recent FDA "safe to proceed" letter to continue ovarian cancer treatment. If it actually materializes, could see a run towards levels above. It...
Catalyst Pharmaceuticals is a biopharmaceutical company that specializes in therapies for rare neurological and neuromuscular diseases. It announced its fourth-quarter and 2020 financial results on March 15, 2021, reporting a 16% increase in revenue for fiscal 2020 and a 30% increase in operating income. (investopedia.com)
The company posted adjusted earnings of...
